Sponsor
Ascopharm Groupe Novasco
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Ascopharm Groupe Novasco appears in 2 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shown24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I CompletionNCT02361242 · collaborator · 2013-06-01
COMPLETEDPilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)NCT02361424 · collaborator · 2013-02-01
COMPLETEDSponsor roles
collaborator2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.